Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Regulatory Roundup, November 2018: Press Scrutiny, FDA Reforms And The Midterms

Executive Summary

The global investigative journalism spotlight on the medtech space had major impact at the end of November and now underlie discussions of FDA reforms, even if the agency was already working on them. Meanwhile, there was a US midterm election in November. Here's the most popular US regulation and policy stories from last month.

Advertisement

Related Content

Pendulum To Swing To More Congressional Oversight Of FDA Device Regs, Hill Experts Say
Nudging Firms To Ditch Older Predicates: A Step In US FDA's Planned 510(k) Reforms
FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments

Topics

Advertisement
UsernamePublicRestriction

Register

MT124340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel